Trial Profile
The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Jun 2015
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Pharmacokinetics
- Sponsors LEO Pharma
- 27 Jan 2013 New trial record